Approvals/TGA/GENRX IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Approved

STANDARD

GENRX IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial

Baxter Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3529a7c460fe0b9d
Product Name: GENRX IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Artg Id: 246732
Artg Name: GENRX IRINOTECAN irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial
Sponsor: Baxter Healthcare Pty Ltd
Company Detail Path: /organization/baxter-healthcare-pty-ltd
Artg Date: 2016-05-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3529a7c460fe0b9d

Type

Standard